Top Abstract Purchase Related
Home
>
Node
>
Subnode

The effects of administering surfactant to two adolescents with leukemia suffering from respiratory distress

Marraro, G.; Casiraghi, G.; Riva, A.

Cahiers d'Anesthesiologie 39(4): 227-232

1991

ISSN/ISBN: 0007-9685
PMID: 1933519
Document Number: 373778
Two adolescents (12 years old, suffering from acute lymphoid leukaemia (LLA) and 16 years old with acute myeloid leukaemia (LMA)) were treated with porcine surfactant (Curosurf). The indication for this treatment was a severe Respiratory Distress Syndrome (RDS) which appeared during leukaemia treatment. Pulmonary thrombo-embolism was suspected. The surfactant administered improved ventilation and oxygenation, enabling confirmation of the diagnosis which would otherwise have been impossible due to the seriousness of their condition.

Document emailed within 1 workday
Secure & encrypted payments

Chida, S.; Phelps, D.S.; Soll, R.F.; Taeusch, H.W. 1991: Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment Pediatrics 88(1): 84-89
Napierala, S. 1992: Surfactant substitution in respiratory distress syndrome. Nursing necessities for the care of a premature with respiratory distress syndrome after surfactant substitution Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 11(7): 253-254
Robertson, B. 1998: Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS) Monaldi Archives for Chest Disease 53(1): 64-69
Soll, R.F.; Hoekstra, R.E.; Fangman, J.J.; Corbet, A.J.; Adams, J.M.; James, L.S.; Schulze, K.; Oh, W.; Roberts, J.D.; Dorst, J.P. 1990: Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group Pediatrics 85(6): 1092-1102
Enhorning, G. 1983: Surfactant in the treatment of respiratory distress syndrome Progress in Clinical and Biological Research 135: 267-272
Mlyncek, M.; Bánovcin, P.; Mlynceková, D. 1989: Surfactant in the therapy of respiratory distress syndrome Ceskoslovenska Gynekologie 54(7): 516-523
Chotigeat, U.; Promwong, N.; Kanjanapattanakul, W.; Khorana, M.; Sangtawesin, V.; Horpaopan, S. 2008: Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods Journal of the Medical Association of Thailand 91(Suppl 3): S109-S114
Balamugesh, T.; Kaur, S.; Majumdar, S.; Behera, D. 2003: Surfactant protein-A levels in patients with acute respiratory distress syndrome Indian Journal of Medical Research 117: 129-133
Horoz, O.O.; Yildizdas, D.; Yilmaz, H.L. 2009: Surfactant therapy in acute respiratory distress syndrome due to hydrocarbon aspiration Singapore Medical Journal 50(4): E130-E132
Verhagen, A.A.; Keli, S.O.; van der Meulen, G.N.; Wiersma, H.; Arias, M.; Angelista, I.R.; Muskiet, F.D. 2001: Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao West Indian Medical Journal 50(2): 117-122
Charon, A.; Taeusch, W.; Fitzgibbon, C.; Smith, G.B.; Treves, S.T.; Phelps, D.S. 1989: Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome Pediatrics 83(3): 348-354
Wu, C.H.; Kua, K.E. 1997: Exogenous surfactant therapy for neonatal respiratory distress syndrome: a two-year clinical experience Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 38(6): 463-467
Gross, N.J. 1991: Inhibition of surfactant subtype convertase in radiation model of adult respiratory distress syndrome American Journal of Physiology 260(4 Pt 1): L311-L317
Faurschou, P.; Sigurd, B. 1982: Fatal respiratory distress syndrome in an adult suffering from amitriptyline poisoning Ugeskrift for Laeger 144(51): 3838-3839
De Vries-van de Vlugt, B.C.; Lentjes, E.G.; Romijn, F.P.; Berger, H.M.; Massa, G.G. 1997: Glucocorticoid receptors in cord blood lymphocytes of healthy neonates and of preterms suffering from respiratory distress syndrome Acta Paediatrica 86(12): 1350-1355
D.V.ies Van, D.V.ugt, B.C.M.; Lentjes, E.G.W.M.; Romijn, F.P.T.H.M.; Berger, H.M.; Massa, G.G. 1997: Glucocorticoid receptors in cord blood lymphocytes of healthy neonates and of preterms suffering from respiratory distress syndrome Acta Paediatrica 86(12): 1350-1355,.
Marraro, G.; Foresti, B.; Casiraghi, G.; Monici Preti, P. 1991: Follow-up on infants treated with porcine surfactant replacement for severe neonatal and infant respiratory distress syndrome: antigenic reactivity evaluation Drugs under Experimental and Clinical Research 17(10-11): 511-515
Sell, M.; Cotton, R.; Hirata, T.; Guthrie, R.; LeBlanc, M.; Mammel, M.; Long, W. 1995: One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I Journal of Pediatrics 126(5 Pt 2): S20-S25
Leroux, B.; Mesmin, F.; Morville, P.; Chevallier, D.; Behar, C.; Ferrand, O.; Potron, G.; Coffin, R. 1975: Disorders of hemostasis and respiratory distress in the newborn infant: hyaline membrane disease and transient respiratory distress Archives Francaises de Pediatrie 32(3): 300
Hegyi, T.; Hiatt, I.M.; Stile, I.L.; Zolfaghari, S. 1986: Effects of postnatal aminophylline on the course of respiratory distress syndrome in premature infants Clinical Therapeutics 8(4): 439-449